Episode Details
Back to EpisodesVaccine Progress and What’s Next
Published 5 years, 10 months ago
Description
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices